Good day, everyone, and welcome to the Thomson Reuters Q4 2023 earnings call. Today's conference is being recorded. At this time, I'd like to turn the call over to Gary Bisbee. Please go ahead, sir. Thank you, Jennifer. Good morning, and thank you everyone for joining us today for our fourth quarter 2023 earnings call. I'm joined today by our CEO, Steve Hasker, and our CFO, Mike Eastwood, each of whom will discuss our results and take your questions following the remarks. To enable us to get to as many questions as possible, we'd appreciate it if you would limit yourself to one question and one follow-up when we open the phone lines. Throughout today's presentation, when we compare performance period on period, we discuss revenue growth before currency as well as on an organic basis. We believe this provides the best basis to measure the underlying performance of the business. Today's presentation contains forward-looking statements and non-IFRS financial measures. Actual results may differ materially due to a number of risks and uncertainties discussed in reports and filings that we provide to regulatory agencies. You may access these documents on our website or by contacting our investor relations department. Let me now turn it over to Steve Hasker. Thank you, Gary, and thanks to all of you for joining us today. 2023 was a year of continued progress at Thomson Reuters, but let me start by reviewing some of our key accomplishments. Firstly, we delivered another year of good financial results, meeting or exceeding our key financial targets. Full-year organic revenue grew 6%, with the fourth quarter growing at 7%. The Big 3 segments also accelerated in Q4, growing 8% versus 7% for the full year. Despite lingering inflationary pressures and heavy investment, our full-year adjusted EBITDA margin rose by 420 basis points to 39.3%, and we delivered $1.9 billion of free cash flow, slightly ahead of target. Although the macroeconomic and geopolitical backdrop remains uncertain, we have many areas of strength in our portfolio. Westlaw Precision's strong performance continues. Our international businesses maintain their growth trajectory in the teens, and we have many other products delivering double-digit revenue growth, including Practical Law, Confirmation, SurePrep, and HighQ. 2023 saw significant and important progress from an innovation perspective. The clear highlight was our efforts around generative AI, culminating in the November launch of the AI-assisted research capability within Westlaw Precision. But the progress is far broader than just Westlaw. We have integrated our new colleagues from the August acquisition of Casetext, launched CoCounsel Core to extend the reach of Casetext's legal AI assistant offering, and we are working to deliver against a robust product roadmap that includes several key launches in the next few months. Our capital capacity and liquidity remain a key asset that we are focused on deploying to create shareholder value, and we made strong progress on this during 2023. We monetized nearly $5.5 billion of our stake in LSEG and returned more than $3 billion to shareholders. Since the beginning of 2023, we have invested nearly $2.1 billion in six acquisitions, including our purchase of a majority stake in e-invoicing leader Pagero. These acquisitions bolster key franchises and improve the quality and growth prospects of our portfolio. Looking forward, our conviction around the medium-term growth potential for Thomson Reuters is rising. As we stated last quarter, we're accelerating investment in 2024 to take advantage of our potential, particularly around our generative AI offerings and recent acquisitions. As Mike will discuss in more detail, we are guiding for organic revenue growth of approximately 6% in 2024, and we're focused on driving acceleration from that level in 2025 and beyond. To that point, we're also introducing a financial framework for 2025 and 2026, in which we see organic revenue growth of 6.5%-8%. Now to the results for the quarter. Our fourth quarter organic revenues grew 7%, improving from 6% in recent quarters. Organic, recurring and transactional revenue grew 7% and 16%, respectively, while print revenue declined modestly as expected. Reported revenue grew 3%, with currency a slight drag and net divestitures having a 4% negative impact. Adjusted EBITDA increased 12% to $707 million, reflecting a 300 basis point margin improvement to 38.9%. The margin expansion was driven by change program expenses in the prior year and high margin contribution from Reuters' transactional revenue. Adjusted earnings per share grew 31% from the prior year period to $0.98. Turning to the fourth quarter results by segment, the Big 3 businesses delivered 8% organic revenue growth, an all-time high, and up from 7% in recent quarters. Legal organic revenue growth improves to 7%, driven by continued Westlaw Precision momentum. Demand for our key offerings remains healthy, led by Westlaw, Practical Law, Casetext, and strong performance in our international markets.... Customer interest in our AI-driven offerings and product roadmap remains extremely strong, with several additional launches coming in the next few months. Corporates' organic revenue growth was 7%, in line with the growth last quarter. Both recurring and transactional revenues grew 7%. Practical Law, Indirect Tax, CLEAR, and our international regions remain key growth drivers. Tax and Accounting organic revenues grew 10%, driven by recurring and transactional growth of 10% and 14% respectively. Our Latin America operations, UltraTax, and SurePrep, each contributed meaningfully to growth. Reuters News organic revenues rose a robust 9%, driven primarily by generative AI-related content licensing revenue that was largely transactional in nature. Sluggish digital advertising and events growth continued, amid uneven macro conditions and a change in the timing of events versus last year. Lastly, Global Print organic revenues met our expectations, declining 4% year-over-year. In summary, we're pleased with our results and the solid momentum in the business. Full-year organic revenues rose 6%. Reported revenue grew 3%, with currency a slight negative impact and net divestitures a 3% drag. Adjusted EBITDA increased 15% to $2.7 billion, with a 39.3% margin up 420 basis points year-over-year. Revenue growth and having changed program expenses in the prior year drove the margin gain. Adjusted earnings per share for the year was $3.51, compared to $2.62 per share in the prior year. And let me finish on the financials for the full year by noting we met or exceeded all of our 2023 guidance metrics. Now I'll spend a few minutes discussing 2023 product highlights and progress executing on our M&A strategy. Product and innovation remains an important focus, and in 2023 was a year of tremendous progress for our product and engineering organizations. The emergence of GPT-4 and advanced generative AI technologies ushered in significant change for our product organization, which had to reprioritize on-the-fly, reimagine customer experiences, and then quickly deliver TR quality product innovations. Our teams have moved with a speed and decisiveness never seen before at Thomson Reuters, and we're beginning to see tangible results from these efforts. The launch of the AI-assisted research capability within Westlaw Precision in November has gone well. Customer feedback remains positive, and fourth-quarter sales set records for the Westlaw franchise. We have also made good progress with Casetext, including the launch of CoCounsel Core, a robust package of legal workflow tools offered through Casetext's Legal AI Assistant. 2023 also featured a broad range of expanded features, new capabilities, and design enhancements across our portfolio, including several listed on this slide. Looking into 2024, we're excited about our product roadmap, which includes a series of important launches and capability enhancements. This includes adding generative AI capabilities to Practical Law and Checkpoint, and the launch of Practical Law Clause Finder, and also an intelligent drafting solution delivered through Microsoft Word. We also plan to bring CoCounsel Core and Westlaw GenAI capabilities to several key international markets and add a number of new skills to the CoCounsel Legal AI Assistant. We look forward to highlighting a number of our product innovations at our upcoming Investor Day. 2023 was also an eventful year for Thomson Reuters from a capital allocation perspective. I'll leave the discussion of shareholder returns to Mike and focus here on our progress at putting capital to work through acquisitions. Since the beginning of 2023, we've invested nearly $2.1 billion in six acquisitions. Through these purchases, we've added important capabilities to each of the Big 3 segments. We completed two strategic tuck-ins at Reuters News and taken full control of Westlaw Japan after buying out our former joint venture partner. A few summary thoughts. Casetext added critical capabilities and talent to accelerate our GenAI aspirations in Legal Professionals, and over time, more broadly across the entire TR portfolio. SurePrep and Pagero have added leading-edge technology that complements our existing capabilities and allows for truly end-to-end workflow automation solutions for our Tax and Accounting and Corporates markets, respectively. At Reuters, we've added a compelling media asset management technology for our agency business through Imagen and subscription professional content focused on the insurance industry, both aligned with the growth strategy of this business unit. These acquisitions deepen our focus on content-enabled technology, which is what we do best. They also continue our efforts to execute the TR acquisition playbook. This entails acquiring high-quality businesses, integrating them into TR's product suite, investing behind their growth, and leveraging our extensive distribution and customer relationships to drive profitable long-term growth.... While it remains early, integration efforts are off to a good start. Customer feedback has been strong, and we're retaining key talent at a very high rate. When we consider these acquisitions in total, we've added approximately $200 million of revenue, growing at strong double digits. This is slightly more than the revenue divested through the sale of a majority stake in Elite, which was not growing. As a result, our portfolio today is stronger, more strategically aligned with better growth prospects than it had 18 months ago. Let me provide a bit more discussion of the Pagero acquisition. Note that we went into significant detail about Pagero on an investor call on January 19th, so I'll just summarize a few points here. First, the e-invoicing opportunity is significant, and we see strong growth continuing as planned implementation of digital tax regulations in more than 80 countries brings a wave of regulatory-driven demand growth. Second, Pagero is a market leader with what we believe are differentiated solutions. In addition to offering a single global platform, which is unique in the market, the company's modern technology and robust compliance capabilities are market-leading, in our view. Third, Pagero is a compelling product fit with Thomson Reuters. The combination of Pagero's e-invoicing compliance offerings with our ONESOURCE Indirect Tax solutions should yield significant benefits for our customers, including enhanced compliance capabilities, better end-to-end workflow automation, and global scale through a single trusted vendor. Fourth, Pagero has an attractive financial model with strong long-term growth and profit potential. The company has a proven track record of double-digit revenue growth and is highly profitable in its scaled markets. We see a pathway to robust overall profitability in the next few years as its investment markets scale up. And finally, our current ownership of Pagero is approximately 85%. Assuming we acquire 90% or higher ownership by the end of our tender offer period, we will look to undertake a squeeze-out process in order to take full ownership of the business. We'll consolidate Pagero's financials as of January 17th, the day we achieved majority ownership of the company. Mike, over to you. Thank you, Steve, and thanks for joining us today. As a reminder, I will talk to revenue growth before currency and on an organic basis. Let me start by discussing the fourth quarter revenue performance for our Big 3 segments. Organic revenues improved sequentially from 7% in recent quarters to 8% in the fourth quarter, a new high-water mark for the Big 3. Total revenue rose 3%, including the impact of divestitures. Legal Professionals' organic revenue grew 7%, driven by continued Westlaw Precision momentum. Key drivers from a product perspective remain Westlaw, Practical Law, HighQ, and our international businesses, with Casetext also contributing. Government grew 7% in the quarter, while FindLaw was a modest headwind to the segment growth rate. We expect good momentum for Legal Professionals to continue into 2024. Our Westlaw Precision AI-assisted research launch in November contributed to another strong quarter for Westlaw Precision sales. I am happy to announce Precision penetration continues to rise, hitting 26% as of December 31st, which on a dollar basis is approximately 50% ahead of Edge. In our corporate segment, organic revenues again grew 7%, driven by 7% growth in both recurring and transactional revenue. Practical Law, CLEAR, and our international businesses were key drivers. Tax and Accounting had another good quarter, growing 10% organically. Recurring and transactional revenue grew 10% and 14%, respectively. Latin America remains a key driver for our Tax and Accounting segment. Looking to 2024, we expect transactional revenue growth will continue to outpace recurring revenue as higher growth products, including Confirmation and SurePrep, are transactional in nature. Moving to Reuters News, organic revenue increased 9% for the quarter, driven primarily by growth from generative AI content licensing revenue. We expect additional licensing revenue in the first quarter of 2024, which will likely drive at least mid-teens growth for the segment in Q1. The revenue from these agreements is largely transactional. Lastly, Global Print organic revenues declined 4%. This was in line with our expectations. On a consolidated basis, fourth quarter organic revenues grew by 7%. Turning to our profitability, adjusted EBITDA for the Big 3 segments was $624 million, 1% better than the prior year period, with a 43.1% margin declining 80 basis points. The year-over-year decline results from timing normalization of certain expenses, select growth investments and productivity initiatives, as well as dilution from 2023 M&A.... Moving to Reuters News, adjusted EBITDA was $61 million, up $21 million from the prior year period, with a margin of 27.9%. The AI content licensing agreement I mentioned earlier contributed meaningfully to profit growth, adding approximately 6.5% to Reuters segment margin in the quarter. Global Print adjusted EBITDA was $55 million, with a margin of 36.4%, an increase of 30 basis points. Excluding foreign exchange impacts, segment margins would have eased lower. In aggregate, total company adjusted EBITDA was $707 million, a 12% increase versus Q4 2022. The combination of Reuters AI revenue and a slight favorability in some of our expenses contributed to a better than expected adjusted EBITDA margin for the fourth quarter. Turning to earnings per share. Fourth quarter adjusted EPS was $0.98, up from $0.75 in the prior year period. Higher adjusted EBITDA, a lower share count, and lower interest expense drove the year-over-year growth. Currency had a $0.02 favorable impact on adjusted EPS in the quarter. Let me now turn to our free cash flow performance for the full year. Reported free cash flow was $1.87 billion, up 40% from $1.34 billion in the prior year period. Consistent with previous quarters, this slide removes the distorting factors impacting our free cash flow. Working from the bottom of the page upwards, the cash inflow from discontinued operations was $14 million, which is an $81 million improvement from the prior year period. Also, in the 12 months, we made $90 million of change program payments, as compared to $324 million in the prior year period. If you adjust for these items, comparable free cash flow from continuing operations was $1.94 billion, $216 million higher than the prior year period, primarily due to higher EBITDA. I will now provide an update on our capital structure and several capital allocation items. As you can see, our capital structure and liquidity position remain quite strong as we exited 2023. We had $1.3 billion of cash on hand at December 31st. We have an undrawn $2 billion revolving credit facility, and we also have approximately $1.9 billion of availability on our $2 billion commercial paper program. Our December 31st leverage ratio was 0.8x, below our 2.5x internal target, as noted in our value creation model. We will use approximately $800 million of cash on hand to fund the Pagero acquisition, leaving our leverage ratio well below our target. Next, I will provide several updates on our London Stock Exchange Group holding. In 2023, we sold 56 million shares for nearly $5.5 billion of gross proceeds. Of the remaining 16 million shares we own, 2.6 million could be sold through exercise of the call options we sold in September, and we have 6.1 million additional shares that are eligible for sale in 2024. Our tax basis on the remaining 16 million shares is approximately $650 million. For your math, we would assume a 25% capital gains tax rate on gains above $650 million. Lastly, the value of foreign exchange hedges held against our LSEG stake were $26 million as of December 31st. We currently have approximately 86% of our remaining LSEG position hedged. From a liquidity and capital structure standpoint, we remain in an enviable position with below target leverage and strong cash flow, bolstered by proceeds from the monetization of our LSEG stake. We remain focused on value creation, and we expect to continue with our balanced capital allocation approach that includes annual dividend growth, strategic M&A, and capital returns. We have ample capacity to pursue all three of these strategies in 2024 and beyond. Steve touched on our approach to M&A and recent Pagero acquisition, so I will focus on the two other key components of our balanced capital allocation approach. We are progressing with the $1 billion NCIB or share buyback we announced last November, having repurchased approximately $500 million worth of our shares as of the end of January. We anticipate completing the program in the second quarter. Finally, today, we announced a 10% increase in our annual dividend to $2.16 per share, up $0.20 from $1.96 in 2023. This marks the 31st consecutive year of annual dividend increases for the company and the third consecutive 10% increase. The increase will be effective with our Q1 dividend payable next month. Let me conclude with a discussion of our 2024 outlook and a financial framework for our expectations in 2025 and 2026. Starting with 2024, we forecast organic revenue growth of approximately 6%. We see total revenue growth of approximately 6.5%, slightly outpacing the organic growth rate due to the benefit from recent M&A, net of the Elite divestiture. We see the Big 3 segments growing revenue by approximately 7.5%, continuing the strong trend of modest acceleration we have seen in recent years. One point to note on the revenue outlook, it is negatively impacted by accounting for the hyperinflationary environment in Argentina, which dilutes our organic revenue growth calculation by approximately 40 basis points. Absent this impact, our outlook would call for modest organic revenue growth acceleration in 2024, driven by underlying improvement from all GenAI initiatives and acquisitions. M&A is expected to contribute approximately 50 basis points to our 2024 growth. We are forecasting a 2024 adjusted EBITDA margin of approximately 38%, down from 39.3% in 2023. Our M&A activity since mid-2023 is expected to be roughly 120 basis points dilutive to 2024 margins, which includes 35 basis points of integration expenses that we expect to fall off within 24 months. As we previewed last quarter, we are choosing to reinvest our underlying operating leverage in 2024 into accelerated organic investments, particularly in the generative AI area. We do not take this decision lightly, but we see significant opportunity through these investments to expand our medium to longer-term growth profile. As I mentioned last quarter, we expect our effective tax rate to rise in 2024, driven primarily by the implementation of OECD global minimum tax regulations across several key markets. We now expect an effective tax rate of approximately 18% this year, up from 16.5% in 2023, but below our initial expectation for 19% discussed last quarter. Moving to capital intensity, we see 2024 accrued CapEx as a percent of revenue of approximately 8.5%. This is broadly a continuation of the level for 2023, with a slight increase related to Pagero. This level of spend includes incremental investments in M&A-related integration and more broadly in product development, including in support of our generative AI product roadmap. We forecast 2024 free cash flow of approximately $1.8 billion. This include an expected increase in cash taxes of roughly $90 million, higher year-over-year CapEx of approximately $90 million, and lower dividends from our LSEG stake resulting from the 2023 monetizations. For the CapEx increase, note that approximately two-thirds of the increase results from integration costs and growth investments in Casetext and Pagero. Let me call out one other modeling note for 2024. We expect to transition approximately $20 million of revenue from our Global Print business into our legal professional segment in 2024. This content has been added to Westlaw, which we believe will provide customers with a richer experience. We see this transition aiding our legal professional segment organic revenue growth by approximately 80 basis points and reducing the growth rate of our Global Print segment by approximately 400 basis points. This transition is expected to be substantially complete by the end of 2024. Turning to the first quarter, we expect organic revenue growth to be approximately 8%, boosted by the expectation for additional AI licensing revenue at Reuters. We see our first quarter adjusted EBITDA margin at approximately 40%, benefiting from normal seasonal strength from our Tax and Accounting professional segment and the Reuters licensing revenue, partially offset by M&A dilution and select growth investments. Looking beyond 2024, we are focused on delivering further revenue growth acceleration and a return to margin expansion. For the 2025-2026 period, we forecast an organic revenue growth range of 6.5%-8%, driven by 8%-9% for the Big 3 segments. We will work to deliver acceleration within this range over the next few years as our GenAI investments pay off and recent M&A scales. For margins, we anticipate delivering 75 basis points of expansion in 2025, followed by at least 50 basis points annually thereafter. I would note this is an organic outlook and could be impacted by future M&A. We expect our capital intensity to remain at approximately 8%, but relatively stable with the recent trend. After some of our acquisition integration spending moderates, we expect our free cash flow to remain robust over the next several years, growing to a range of $2 billion-$2.1 billion in 2026. This assumes some further increase in our effective and cash tax rates beyond 2024, stable capital spending, and rising margins. We are also providing medium-term targets for several capital strategy-based metrics. This includes maintaining our 2.5x leverage target and a dividend pay, dividend payout ratio of 50%-60% of free cash flow. We are making a new commitment to return at least 75% of our free cash flow annually in the form of dividends and share repurchases. We target a return on invested capital that is double or more, our weighted average cost of capital over time. On this point, the accounting for M&A can depress ROIC in the short term, though we would expect our returns to continue to rise on an organic basis. We look forward to providing more detail around the drivers of this outlook at our planned Investor Day on March 12th in New York City. With that, I will hand it back to Gary for questions. Thank you. Jennifer, we're ready to begin the Q&A. Thank you. If you'd like to ask a question, please signal by pressing star one on your telephone keypad. If you're using a speakerphone, please make sure your mute function is turned off to allow your signal to reach our equipment. Again, that's star one if you'd like to ask a question. We'll go first to Scott Fletcher from CIBC. Hi, good morning. Mike, I appreciate you just mentioned that you'll share some of the drivers at the Investor Day, but I'm wondering if you could, just looking at the 2025 and 2026 acceleration in organic growth, particularly in the Big 3, could you sort of give us an idea of which segments specifically are going to be driving that acceleration? Is it mostly legal, given that GenAI rollout is first there, or any color there would be helpful. Thank you. Sure, Scott. Thanks for the question. We see growth acceleration across all the Big 3 segments over the time horizon, 2025 to 2026. Certainly, to your point, with the legal, with GenAI and the roadmap that we started there, Westlaw Precision, with the CoCounsel Core, the Ask Practical Law AI, and the Practical Law Clause Finder, certainly legal has a head start there on the GenAI roadmap. But just given the opportunities across the horizon, Scott, to achieve that 6.5%-8% organic growth, we see acceleration across all three segments. And I think, Scott, just as a reminder, if you think about that acceleration to 6.5%-8%, the product roadmap, the investments we made in 2023, the investments in 2024, but also the recent acquisitions in the last 13 months, excuse me, with SurePrep and Tax and Accounting, Casetext and Legal, and then Pagero with Corporates, with e-invoicing and Indirect Tax. Given that those acquisitions cross the Big 3 segments, that's what gives us the additional confidence that we'll see acceleration across the Big 3, Scott. Okay, thanks. And then as a follow-up, if we're thinking about that in the Big 3, 8%-9% organic growth in 2025 and 2026, is that something you see as sustainable, those levels? Or is that a function somewhat of the price increases rolling out over the contract lengths, given you've got sort of 3-year terms that would take you into 2026? So certainly as we get into that 2025, 2026 time horizon, the 8%-9% for the Big 3 will be sustainable. Price increase is certainly a component of that, Scott. I think I shared in the November earnings call on a weighted average basis, about 3.5%, on the composite, which was up about 30-40 basis points versus calendar year 2022. The multiyear contracts that you mentioned certainly play a factor into the time of when we increase our prices, but roughly 3.5% for 2023, Scott, on the prices. Just to Scott and Steve, just to add to that, I think that the confidence around the sustainability of that elevated growth comes from both our organic investment, investments and inorganic. So on the organic front, what we're starting to see, and it is very few days, is an expanded role in serving the professionals that are in our customer bases. And we think that that's going to make us, you know, an even more relevant and larger part of their working lives. And then on the inorganic, you know, I made reference in my remarks to the portfolio shift to some higher growth assets and businesses. So it's really the combination of those two things that gives us confidence around the sustainability of those higher growth rates going forward. Scott, I might be anticipating questions from you or others. Just a reminder, within the GenAI revenue, I think, Gary, Steve, and I plan to provide additional metrics as we progress during 2024 on that, but the revenue will certainly lag on the sales of GenAI, which we anticipate revenue from the GenAI beginning to pick up more in the second half of 2024, and that goes into 2025, if helpful. Okay, great. Thank you very much. Thank you. We'll go next to Drew McReynolds from RBC. Yeah, thanks very much. Good morning. Can you hear me? Very well, Drew. Okay, super. Yeah, my, my question is just around the competitive landscape, specifically either new entrants or your, your peers that are also deploying GenAI. Just would love to get an update on kind of what your assessment of, of that would be, just given the pace of change and everybody kind of launching their own GenAI versions of different products. And then maybe a follow-up to that. Steve, in the past, you, you've talked a little bit about the end markets that you serve and the transition or transformation that inevitably will be taking place at law firms and tax and accounting firms. What have you seen to date? Presumably not a lot, but if not, you know, when do you think those end markets begin to accelerate their pace of transition? Thank you. Yeah, thanks, Drew. Great questions. So, with regard to the competitive landscape, I think we're seeing, I'm sure you're seeing, so a lot the flurry of announcements of, of new entrants, of some of our traditional competitors, you know, making moves. You know, I, I can only really comment on, on the conversations that I have and, and my colleagues have with, with our customers, be they existing customers or new prospects. And the feedback we're getting on our both launches to date and, and our product roadmap is extremely positive and growing. And I think that's based on a couple of different things. You know, particularly for those customers who've had a chance to really kick the tires on our offerings and test the accuracy and incremental value of our offerings relative to some of the competitors. You know, our repositories of content are deeper and broader than anyone else in the industries that we serve, particularly in legal. And that is being recognized as a key value component in any GenAI-driven solution. Secondly, you know, we enjoy but don't take for granted very deep and broad customer relationships and their trust-based customer relationships. So in terms of, in terms of doing it right and protecting client proprietary information, and all the sort of data privacy rules that, that will inevitably come as GenAI evolves, there's a level of trust in TR's plans and execution, I should say. And then thirdly, talent. You know, we've, as you know, we've put a lot of effort into making sure that we have the best product and engineering and labs teams, and we're just starting to scratch the surface in terms of, in terms of the results of that. So those three things, you know, give us a lot of confidence coming out of 2023 into 2024. But I would also say it's early days. You know, I think this sort of GenAI-driven transformation will be a multiyear journey, and we're certainly not going to rest on our laurels based on what we've been able to achieve in the early going. And that sort of, I think, leads to the second part of the question. You know, the good news is, as we explore with our customers, the role of Thomson Reuters' content-driven technology in their work lives, we just see that role expanding, as I said, in response to Scott's question. You know, we see a world in which, you know, a customer in a year or two's time, perhaps, perhaps longer, perhaps shorter, says, "Well, that was Thomson Reuters, who I traditionally—my, my chief knowledge officer or my librarian, leaned on for many, many years to provide great content. And now I'm really running my practice. I'm running my business, I'm running my department on their content-driven technology." We see a fairly clear line to that expanded role. But your point about adoption, we also see as that role expands, we see a greater need for change management at the customer site, and some customers are expecting us to be very much front and center to that, change management program, and others are keen to sort of navigate a lot of that themselves. I think it's early days, Drew, in terms of that, their scoping out of that change management and figuring out what it looks like and what resources will be required over what period of time. But we'll certainly be shoulder to shoulder with them as they figure that out. Very helpful. Thank you. Thank you. We'll go next to Kevin McVeigh from UBS. It's Kevin McVeigh from UBS. I just want to start and just... I typically don't do this, but just congratulate the execution you folks have had because it's been a major transformation in the business, and it, it's really gone flawlessly. So I just, I wanted to call that out because I think it's really important. I don't know if this is for Steve or Mike, but, you know, when you think about those medium-term targets, you know, kind of going from 6% to 6.5% to 8%, is there any way to think about, build that up a little bit? How much of that is, is retention versus pricing? And then-... You know, you've done a lot of high-growth acquisitions that are in the base now. Maybe how that contributes, because it feels like a first step to me, as opposed to, you know, a ceiling, if you would. But, maybe, can we start there? Yeah. Can I just, I'll just make a comment or two, or a reaction or two, Kevin, to your questions, and then turn it over to Mike. So, thanks for your points about execution, Kevin. We're proud, but I hope not arrogant about the work we've been able to get through. We were very deliberate back in way back in 2020 and saying: We're going to go through this change program, and in doing so, we'll make a two-part pivot, first from portfolio to operating, and second, from holding to... Sorry, from holding company to portfolio, to operating company, and then from content to content-driven technology. And we're, you know, we've achieved a lot in getting through that. Kudos to Kirsty Roth and Jason Escaravage, to Mary Alice Vuicic, to Shawn Malhotra, and a legion of others who've really driven a lot of that hard work and, and, and, and executed along the way. And as a group, I think we've learned a lot, and we're getting stronger and stronger. As it pertains to, you know, some of the key metrics that we're very focused on, like Net Promoter Score and net recurring revenue, the sort of broader set of customer success metrics, we're just getting started. You know, I think there's a sort of an appropriate level of modesty as to how much progress we've made and how much upside there is for our Big 3 segments, should we be able to accelerate and build more momentum. But over to you, Mike. Yeah, Kevin, you touched on the key building blocks. I would just emphasize retention, price, M&A, and new product. In regards to retention, as I've shared in prior calls, we're roughly 91% of revenue. That's based on... I'm sorry, retention, that's based on revenue of total TR. That significantly varies between small customers, mid-size customers, and large customers, with our largest customers having the largest or the highest retention rates. I would anticipate pricing being relatively stable over the time horizon. If you look at the recent acquisitions in the last 13 months, SurePrep, Casetext, and Pagero, certainly they are a key component of that acceleration as we go into 2025 and 2026. I would just call out Dave Wyle, who is the co-founder, leader, CEO of SurePrep. We're into 14 months now with Dave, and incredibly pleased and proud of Dave and the team being part of TR. Then we go to Casetext with Jake Heller and his team. We have five, six months into a great progress there, and then most recently with Pagero. So as we do that walk or build to 6.5%-8%, those recent acquisitions are certainly key factors. And then we go to the fourth factor with the new products. We're quite confident, probably more confident than my tenure at TR and our product roadmap. We've talked a hell of a lot about legal, and Emily Colbert, Mike Dahn, Jake Heller done a great job, and others with the product roadmaps for legal. But then if you think about Tax and Accounting professionals, already double digit with Piritta and team leading the product roadmaps there and Corporates with Ray Grove and IDT, I think that gives us just the, just the confidence. If you think about those four main levers of retention, price, acquisition, and new product, it is the combination of those four, Kevin, that gives us the confidence to achieve that 6.5%- 8%. The one that we will provide you with more visibility on as we progress during 2024 is our GenAI. Because as that evolves and really builds up a lot of momentum, a lot of confidence there, that we'll provide additional quantitative information on GenAI evolution during the course of 2024. Great. That was very helpful. I'm just—I'll leave it at one just because it was, I know it was a long-winded question, so thank you. Thanks, Kevin. Thanks, Kevin. Thank you. We'll go next to Tim Casey with BMO. Thanks. Good morning. Can you talk a little bit about your international aspirations? It seems there's more commentary on expanding into international markets on this call. I don't know if I'm overthinking that, but in the past, you've, I think the strategy has been to grow with your multinational corporates internationally, and now it seems some of the product sets, and certainly Pagero, have a more international footprint. Any thoughts there would be helpful. Thanks. Yeah. Thanks, Tim. You know, as you've seen over a number of years now, our international assets are a source of pride insofar as, you know, they've been growing in the mid-teens, certainly Latin America, higher than that, and I am a little bit lower. And it just reflects the focus of Adrian Panini in Latin America and Jackie Rhodes in AEM, one of their customers, customer-facing here in Canada, Europe, the same. So, you know, while today it's around about 20% of our revenues, international, so it's a relatively modest part of the overall business, we do see higher growth prospects in those markets. And that really comes from, as you say, the opportunity in Corporates, to better serve corporations across the world with our legal and our tax and risk solutions. Pagero is an asset that's heavily focused on the international markets and the invoicing space, so we see lots of potential to really have that as a core driver. And of course, Casetext, with its CoCounsel product. You know, that is perhaps not constrained in the same way that traditional research products have been to common law markets and sort of case law precedent markets. You know, the CoCounsel skills are just as relevant civil law markets as they are anywhere else. So, really, on the back of those and the continued performance of the Domínio assets in Brazil, the acquisition of Westlaw Japan, we're increasingly bullish about what we can do in international markets. And I would add one other thing, which is, you know, the higher those growth prospects become and the more sort of organic and inorganic opportunities we see, I think the more exciting career paths it provides to many of our talented folks who want to spend time in markets, and some of the international talent who want to spend time in North America. And certainly, Mary Alice and her team have been very focused in creating those pathways for our people. Yeah, Tim, I would say the two points. Our Latin America revenue has doubled in the last three-year period, driven by Domínio. At our March 12th Investor Day, Matt Keen, we have a section dedicated to international businesses and international growth aspirations. Thank you. Thank you. We'll go next to George Tong with Goldman Sachs. Hi, thanks. Good morning. You're guiding to organic revenue growth of 8%-9% for the Big 3 in 2025 and 2026, which would be a nice acceleration from 7.5% this year. Can you provide additional details at the segment level on where most of that growth acceleration should come from? Yeah, George, I think we covered quite a bit of that in the earlier comments. I'll just reemphasize those points. Also, during the Investor Day, we will have each of our segment presidents presenting on each of their businesses. And consistent with what we did at the March 2021 Investor Day, whereby we provided organic growth ranges for each of the Big 3 segments, we will once again provide that on March 12th for 2025, 2026, for each of the Big 3. The core points that we mentioned earlier is our product roadmap, significant investments in 2023, even more investments in 2024, across the Big 3 segments. So new product introductions, features, capabilities, including GenAI, across the Big 3. Then the second big vector, George, is the M&A, SurePrep and Tax and Accounting, Casetext and Legal, and then Pagero within the Corporates, specifically in e-invoicing Indirect Tax. So the product pipelines and the M&A are big contributors to our growth profile for 2025 and 2026. Also, back to Kevin's question earlier, retention will certainly play a factor as we expand or increase our retention rates going into 2025, 2026. Got it. That, that's helpful. And then sort of similar question, but around margins. As you look out to 2025, 2026, how would you rank order the margin expansion opportunity across the Big 3? And do you see any reason why structurally, long-term margins should be different across the Big 3 segments? Yes, we will see some margin expansion across each of our Big 3 segments by the time we reach 2025 and 2026. I think over the long term, we will continue to see some deltas or differences between margin across the three. Specifically, within Legal Professionals, we have Westlaw. Westlaw is about $1.8 billion for total TR. Of that, about $1.5 billion is within Legal Professionals, so that provides a significant amount of scale. If you look at Legal Professionals, which is circa $2.9 billion-$3 billion of current revenue. So I think if you look over the long-term time horizon, we'll continue to see a delta between Legal Professionals and Corporates, and also, TAP and Corporates. You'll see Legal and TAP with the higher margins long term there. Got it. That's helpful. Thank you. Indeed. Thank you. We'll go next to Heather Balsky from Bank of America. Hey, it's Wahid Amin on for Heather. Thanks for taking our question. Just wanted to talk more about your M&A. You guys have been pretty, pretty aggressive in the last year, so can you just talk about your M&A pipeline moving forward, and is the strategy still, still the same as, you know, going for higher growth companies or, or going after GenAI- based companies, or have you exhausted that already? Yeah. Thanks, Wahid. So, look, as I remarked, we spent about $2.1 billion over the last 12 or 18 months on six acquisitions, and they've really sort of met or exceeded our criteria, and we think that criteria is pretty rigorous and robust. So, starting with, you know, additive to the customer experience, predominantly in the Big 3, but we've also seen a couple of tuck-ins in Reuters, firstly. Secondly, you know, not bringing tech debt. So, you know, we did a lot of work to clean up our tech debt through the change program. We don't plan to add to it. Thirdly, and I think equally importantly, the ability to take a product which is, you know, which is valued, highly valued by our customers and prospective customers, and really leverage our distribution and our customer relationships to accelerate its growth rate. And that's been a playbook that's served Thomson Reuters well, way back to Practical Law, you know, Westlaw and Practical Law, and certainly been the case with SurePrep. We're optimistic. We're optimistic about the likes of Pagero and Casetext, against that playbook as well. We also look at the culture of the acquired businesses, you know, and it's not to say that we're not looking to diversify our culture and inject, you know, new aspects to it, but we want to make sure that the incentives are right and that the new team will gel with our existing folks. And that's certainly been the case with these recent acquisitions to date. And then last but not least, we want to make sure that there's value creation for our shareholders, not just the selling shareholders. So those deals have very much been against that playbook. And we have a pipeline, you know, that we sort of continually replenish and refresh that's very consistent with that. Some of those potential acquisitions are GenAI-based, you know, but not all of them. But what we do, we try to make sure is that, you know, we're not going to acquire businesses that will be significantly disrupted by GenAI. And so, for example, if we look at content assets, we want to make sure that it's content that has a relevant and robust, valuable role in a large language model environment, you know, not vice versa. So I would say you'll see, you know, more of the same over the next year or two. Very, sort of, very much consistent with that playbook, some of which, you know, directly leveraging GenAI and some we think will have value in that environment over time. Got it. Thank you. Thank you. We'll go next to Manav Patnaik from Barclays. Thank you. You know, I think we've asked the question on acquisitions a lot, but I just wanted to revisit kind of the portfolio that you saw today. You know, you've done a bunch of divestitures the last two years. Just, should we be thinking of more coming down the road? I think you might have considered print at some point. So just wanted to address that topic. Yeah, nothing, nothing imminent, nothing to announce today, Manav. But look, as you've seen, we're pretty rigorous in sort of going through the portfolio on an ongoing basis and making sure that each of the franchises they are in plays a key role in serving our customers. And that the returns on any investment, you know, are the best they can possibly be relative to the alternative. So again, nothing to announce today, Manav, but it is an ongoing, you know, an ongoing effort, and I think always will be, to be candid. Got it. Then, you know, I apologize if I missed this, but just on the topic of GenAI, you know, just trying to appreciate the trade-off between the expenses of the investment versus, you know, versus the growth benefit, I guess, that you're embedding in your 2025, 2026 guidance. I think you said you'd spend, like, $100 million a year on GenAI or something like that. Is that still the case? And is the right way to think about it, that you've made some of the big investments, acquisitions this year, and so now any growth will just help you, you know, leverage the bottom line and hence your guidance? Yeah. So, you're right. With regard to the $100 million investment 2023, we plan to continue at about that intensity. You know, we'll constantly sort of revisit whether that's the right number, and whether we're getting, you know, adequate and exciting returns from that. A couple of things, though, and I don't have the split, but it's worth noting that that pertains to a couple of different things. One is the development of a GenAI platform. So Shawn Malhotra and his team and Joel Hron have built a GenAI platform that serves, you know, firstly, Westlaw Precision AI Research Memo, but also the other legal products, and can and will be extended into other parts of the business, including Reuters News. And so there's a, there's a level of sort of common and shared capabilities. It's not, you know, discrete products. And then, of course, there are the investments required in developing and launching the specific applications like Westlaw, AI Research Memo, like Practical Law, Clause Finder, and so forth, but some of the things I mentioned. So there's two of those things, and, and, and, you know, the, the investment in the platform side of things is probably a little heavier in the early going and then lightens up as we start to start to leverage that across more and more product launches. Thank you. Thank you. We'll go next to Maher Yaghi from Scotiab ank. Great. Thank you for squeezing me in. I wanted to go back to one of the slides at the end of your presentation, talking about your expected debt leverage over the medium term. You're focusing on 2.5x. That's like - to get there, it's about $4 billion of additional acquisitions. So my question is, when we think about return on invested capital for the, for Thomson, how should we think about the movement on that metric as you undertake these kind of significant acquisitions over the, you know, medium term? And a follow-up question on organic growth, for 2025, 2026. How much of the acceleration in organic growth is coming from-... Adding on these companies that you have been buying recently, like Casetext and Pagero, versus your existing portfolio, seeing acceleration in its revenue growth itself. Thank you. Yeah, break those down, Maher, in regards to your questions there. I think you're referring to page 29 of the presentation. First, the net debt leverage 2.5x over the long run. Those of you who have followed us for many years, we've consistently provided our value creation model, which reflects that. We're currently below 1x. To your point, Maher, we have significant flexibility, significant optionality. To Steve's point on his discussions today on M&A, given the opportunities that we see with the pipeline, we have a lot of flexibility. So not much more I can say there, that we're gonna be very, very prudent in deploying our capital, given that we are roughly at 1x today, and 2.5x is our internal target. Our bank covenants provide up to 4.5x, a lot of flexibility. On ROIC, additional focus on that in recent years. Certainly, as we make acquisitions, might there be times where you have some ebb and flows, given the impact of M&A on the ROIC. But I think over the long run, focusing on 2x is why we feel very comfortable on achieving, recognizing that acquisitions can have some near-term impact on that. Your third question on organic growth for 2025, 2026, I'll refer back to Kevin's question earlier today. I think 2025, 2026 revenue growth acceleration, the four vectors I mentioned earlier: retention, pricing, the product roadmap, and then the M&A. You mentioned the M&A specifically in your question. I stated in my prepared remarks about 50 basis points of contribution in calendar year 2024. If you look at 2025, 2026, there'll be additional contribution from the M&A. Thank you very much. Indeed. Thank you. We'll go next to Doug Arthur from Huber Research. Yeah, Mike, can you hear me? Very well, Doug. Yeah. Just quickly, on your margin guidance, specifically for 2024, you know, I mean, you... the company's been notably conservative in their guidance that far out. What, what do you see as sort of the main puts and takes? I know you went through the investment emphasis, but where, where could you be conservative in that margin guide, I guess, is my question? Yeah, the approximately 38% is, is our best lens, Doug, as of today. I'll, I'll just emphasize two points. One, as stated in the prepared remarks, the M&A that we've done recently will dilute our margin by about 120 basis points in calendar year 2024. The other point, Doug, I mentioned during the November earnings call, about 75 basis points is the operating leverage contribution for us. If you assume 6% organic growth, 4% increase in our fixed costs, which are 65%, and then variable costs flow through, that yields about 75%. So given the M&A dilution of 120 basis points, and we're reinvesting the operating leverage, that gets us to that approximately 38%. If there's any variation there, too, during the course of the year, Doug, we'll keep you posted, but that's our best transparent lens today, given those two key items. Nope, makes sense. Interesting framework. Okay, thank you very much. Thank you, Doug. Jennifer, I think we have time for one final question, please. Thank you. We'll go to Sami Kassab from BNP Paribas. Yes, hello. Thank you. Can you hear me? Yes, Sami. Hi, Sami. Yes, thank you. Good morning, gentlemen. We talked a lot about the GenAI contribution onto the top line, but can you help us understand the cost efficiencies that this new technology may help the company achieve in the next two or three years, and perhaps highlight a few initiatives you have ongoing to deploy GenAI internally? Thank you, gentlemen. Yeah, it's a great question, Sami. Thank you. So, Kirsty Roth and Mary Alice Vuicic are spearheading an effort to look end-to-end at our core operations and our functions, to figure out where we can successfully apply generative AI tools. In some cases, you know, with our legal department under Norie Campbell 's leadership, it'll be the internal applications of our own tools, whereas within the engineering and content and editorial areas, it'll be some of the off-the-shelf tools that we all are starting to read about and understand. We're not here to quantify what the sort of financial impact of that will be today, but we're pretty excited about the ability to improve employee sentiment, improve the sort of underlying productivity of the various parts of our company and the team as a whole, and ultimately see some interesting financial benefits. But I think it's too early, Sami, for us to put a stake in the ground. But as we all, under Mike's leadership, we'll be very focused on ensuring that any investments we make in applying those tools across the company, there's an attractive return for our shareholders. Thank you very much. Thanks, Sami. Great. Thank you. Yeah, it does- Thank you, Jennifer. We'll leave it there. Thank you. That does conclude today's conference. Thank you for your participation. You may now disconnect.